Pyruvate kinase I (PykF), encoded by the pykF gene in Escherichia coli, is a critical glycolytic enzyme catalyzing the irreversible conversion of phosphoenolpyruvate (PEP) to pyruvate, generating ATP in the final step of glycolysis . It is one of two pyruvate kinase isoenzymes in E. coli, with PykA (encoded by pykA) serving as the secondary isoform . PykF is allosterically activated by fructose-1,6-bisphosphate (FBP) and exhibits ~15-fold higher activity than PykA under aerobic conditions, contributing 93% of total pyruvate kinase activity in this state .
PykF governs carbon flux through glycolysis and interacts with pathways like the hexose monophosphate (HMP) pathway and PEP carboxylase (Ppc).
Parameter | Wild-Type E. coli | ΔpykF Mutant |
---|---|---|
HMP/Glycolysis Flux | 0.5 | 4.0 |
Ppc Flux | 1.0 | 2.6-fold increase |
Acetate Production | High | Reduced |
ATP Levels | Baseline | Elevated |
PykF deficiency redirects glucose flux to the HMP pathway and Ppc, bypassing acetate formation and increasing ATP availability . This adaptation supports plasmid maintenance and reduces metabolic burden in biotechnological applications .
Lysine acetylation dynamically regulates PykF activity:
Acetylation Mechanisms:
Deacetylation by CobB: The NAD⁺-dependent deacetylase CobB increases PykF activity by removing acetyl groups, particularly at K52, K68, and K317 .
Modification | Effect on Activity | Biological Significance |
---|---|---|
K52/K68 Acetylation | ↓ ATP production | Alters catalytic domain stability |
K317 Acetylation | ↓ ATP production | Minimal impact on extracellular proteases |
PykF is essential for growth on glucose in E. coli and influences pathogenicity:
Growth Under Stress:
UPEC Strains: Loss of pykF reduces fitness in extraintestinal infections, while pykA deletion confers a fitness advantage .
Metabolic Suppression: Suppression of latent enzymes (e.g., Ppc) in the urinary tract maximizes glycolytic flux for colonization .
PykF engineering enhances metabolic flux and reduces acetate accumulation:
Acetate Reduction: ΔpykF strains produce less acetate, improving bioprocess efficiency .
Plasmid Burden Alleviation: Increased HMP/Ppc flux in PykF-deficient strains supports high-copy plasmid maintenance .
Metabolic Engineering: Overexpression of PykF or its acetylation-resistant variants optimizes biofuel (e.g., n-butanol) production .
pykF is a gene in Escherichia coli that encodes Pyruvate Kinase I (PykF), one of two pyruvate kinases present in E. coli K-12. This enzyme catalyzes the formation of pyruvate in the final step of glycolysis, a reaction that is irreversible under physiological conditions. The reaction is critical for controlling metabolic flux in the second part of glycolysis . PykF represents approximately 80% of the total pyruvate kinase activity within the cell during growth, making it the dominant isozyme compared to PykA (Pyruvate Kinase II) .
The PykF protein in E. coli K-12 is a full-length protein of 470 amino acids. The complete sequence is:
MGSSHHHHHHSSGLVPRGSHM GSHM KKTKIVCTIGP KTESEEMLAK MLDAGMNVMR LNFSHGDYAE HGQRIQNLRN VMSKTGKTAA ILLDTKGPEI RTMKLEGGND VSLKAGQTFT FTTDKSVIGN SEMVAVTYEG FTTDLSVGNT VLVDDGLIGM EVTAIEGNKV ICKVLNNGDL GENKGVNLPG VSIALPALA EKDKQDLIFG CEQGVDFVAA SFIRKRSDVI EIREHGGENIHIISIKIENQ EGLNNFDEIL EASDGIMVAR GDLGVEIPVE EVIFAQKMMI EKCIRARKVV ITATQMLDSM IKNPRPTRAE AGDVANAIL DGTDAVMLSG ESAKGKYPLE AVSIMATICE RTDRVMNSRL EFNNDNRKLR ITEAVCRGAV ETAEKLDAPL IVVATQGGKS ARAVRKYFPD ATILALTTNE KTAHQLVLSK GVVPQLVKEI TSTDDFYRLG KELALQSGLA HKGDVVVMVS GALVPSGTT NTASVHVL
PykF interacts with other glycolytic enzymes such as triosephosphate isomerase and phosphoglycerate kinase, ensuring efficient substrate flow and energy generation . These protein-protein interactions likely form metabolic complexes or "metabolons" that enhance reaction rates through substrate channeling, which allows for more efficient transfer of metabolic intermediates between enzymes in the pathway.
When pykF is deleted in E. coli, significant metabolic rearrangements occur:
Flux through phosphoenolpyruvate carboxylase and malic enzyme is up-regulated
Acetate formation is significantly reduced
Flux through the phosphofructose kinase pathway is reduced
Flux through the oxidative pentose phosphate (PP) pathway increases
These changes are accompanied by corresponding alterations in enzyme activities and increases in the concentrations of key metabolites including phosphoenolpyruvate, glucose-6-phosphate, and 6-phosphogluconate .
The effects of pykF deletion on E. coli growth vary depending on culture conditions:
In batch culture with glucose as a carbon source, growth may be moderately affected
In continuous culture, enzyme activities of the oxidative PP and Entner-Doudoroff pathways increase as the dilution rate increases for the pykF mutant
When using ribose as a non-phosphotransferase system-transporting carbon source, growth is significantly impaired, especially when pykA is also disrupted
For a comprehensive understanding of these metabolic changes, it is important to integrate information on intracellular metabolic flux distribution, enzyme activities, and intracellular metabolite concentrations .
Metabolic flux analysis based on 13C-labeling experiments provides the most comprehensive view of metabolic changes in pykF mutants. This typically involves:
Culturing cells with 13C-labeled carbon sources
Measuring intracellular isotope distribution using complementary techniques:
Two-dimensional nuclear magnetic resonance (2D NMR)
Gas chromatography-mass spectrometry (GC-MS)
Measuring activities of related enzymes (16 enzymes were measured in one study)
This integrated approach allows researchers to quantitatively map how carbon flux is redistributed when pykF is deleted, providing insights into the metabolic adaptations that occur in response to this genetic change.
A promising technique for conditional silencing of pykF involves anti-terminated convergent transcription:
λPL is convergently integrated into the chromosome downstream of pykF, face-to-face with its native promoter
In the presence of λ cIts857, efficient temperature-sensitive silencing of pykF can be achieved
The 5′-terminus of the PL-originated antisense RNA (asRNA), consisting of the rrnG-AT sequence, converts elongation complexes of RNA polymerase to a form resistant to Rho-dependent transcription termination
This approach leads to silencing through transcriptional interference due to collisions between converging RNA polymerases, although cis-antisense RNA effects may also play a role .
Acetylation is an important post-translational modification that affects PykF function:
Multiple lysine residues in PykF can be acetylated, including K13, K19, K52, K59, K68, K145, K317, K319, K340, K368, and K382
The deacetylation of different sites has varying effects on acetylation level:
Deacetylation of K52, K68, K317, and K382 significantly decreases acetylation level
Deacetylation of other sites shows no significant difference in acetylation level
PykF activity generally decreases with increased acetylation level
Acetylation occurs in a time- and acetyl phosphate (AcP) dose-dependent manner
The deacetylase CobB can deacetylate PykF, representing an important regulatory mechanism. The site-specificity of acetylation and deacetylation depends on:
Surface accessibility of the target lysine residue
Reactivity of the lysine residue
Three-dimensional microenvironment surrounding the target lysine
These factors determine which lysine residues are most likely to be acetylated or deacetylated under specific conditions, providing a mechanism for fine-tuning PykF activity in response to metabolic changes .
The two pyruvate kinase genes in E. coli show important functional differences:
The effects of pyruvate kinase mutations on E. coli virulence reveal complex interactions:
Loss of pykF results in a defect in bladder and kidney colonization during urinary tract infection
Loss of pykA actually provides a fitness advantage during infection
Interestingly, a pykA pykF double mutant performs similarly to wild-type
This suggests that the presence of Pyk II (encoded by pykA) rather than the absence of Pyk I itself is responsible for the fitness defect in pykF mutants
These findings indicate that E. coli suppresses latent enzymes (like Pyk II) to survive in the host urinary tract
The metabolic changes induced by pykF mutations can be exploited for various biotechnological applications:
Reduced acetate formation in pykF mutants can improve the production of recombinant proteins sensitive to acidic conditions
Increased flux through the pentose phosphate pathway can enhance the supply of NADPH for biosynthetic reactions
Elevated levels of phosphoenolpyruvate (PEP) can be advantageous for PEP-dependent biosynthetic pathways
The conditional silencing of pykF through anti-terminated convergent transcription provides a tunable system for metabolic engineering applications
These properties make pykF an attractive target for rational strain design in metabolic engineering projects.
Research on pykF contributes to our understanding of bacterial metabolic flexibility:
The presence of dual pyruvate kinase isozymes (pykF and pykA) provides E. coli with metabolic redundancy and flexibility
The observation that pykF suppresses potentially detrimental effects of pykA suggests complex regulatory relationships between isozymes
The metabolic rearrangements that occur in pykF mutants demonstrate the remarkable adaptability of bacterial central metabolism
The different fitness effects of pykF and pykA mutations during infection highlight how metabolic flexibility contributes to pathogenesis
These insights have broader implications for understanding bacterial adaptation to diverse environments.
Several complementary approaches can be used to measure PykF activity:
Enzymatic assays: Coupling the production of pyruvate to lactate dehydrogenase activity, which can be monitored spectrophotometrically by measuring NADH oxidation
Western blotting: To quantify PykF protein levels using specific antibodies
RT-PCR: For measuring pykF mRNA levels, which can indicate expression levels
In vivo flux analysis: Using 13C-labeled substrates to trace carbon flow through the pyruvate kinase reaction in living cells
For the most comprehensive analysis, researchers should combine these approaches to correlate enzyme activity with protein and mRNA levels.
Distinguishing between the activities of the two pyruvate kinase isozymes requires specialized approaches:
Genetic approach: Using single knockouts (pykF or pykA) to measure the contribution of each isozyme
Biochemical approach: Exploiting differences in allosteric regulation, substrate affinity, or optimal reaction conditions
Expression analysis: Measuring the expression levels of each isozyme under different growth conditions
Protein purification: Isolating each isozyme for in vitro characterization
These approaches can provide insights into the relative contributions and specific roles of PykF and PykA in different metabolic contexts.
In Escherichia coli (E. coli), there are two isoforms of pyruvate kinase: PykF (pyruvate kinase I) and PykA (pyruvate kinase II). PykF is the more predominant form and is allosterically regulated by fructose-1,6-bisphosphate (FBP). This regulation ensures that the enzyme’s activity is tightly controlled in response to the cell’s metabolic needs.
Recombinant expression of pyruvate kinase I in E. coli involves cloning the gene encoding the enzyme into an expression vector, which is then introduced into E. coli cells. The bacteria are cultured under conditions that induce the expression of the recombinant protein. This method allows for the production of large quantities of the enzyme, which can be purified and used for various biochemical studies.
Recombinant pyruvate kinase I is widely used in biochemical research. It serves as a model to study the regulation of glycolysis and the role of allosteric effectors in enzyme activity. Additionally, it is used in the development of assays to screen for potential inhibitors that could be used as antibiotics or in the treatment of metabolic disorders.